Public sector seeks to bridge 'valley of death'

  title={Public sector seeks to bridge 'valley of death'},
  author={Nuala Moran},
  journal={Nature Biotechnology},
Even while prices for clinical-stage and earlier compounds rise as drug companies compete for assets to fill their pipelines, supporters of academic research have realized they need to pick up the burden of translational research. And as evidenced by recent academic funding schemes in the UK and Australia, that support is growing. “Every public sector funding body around the world is getting into this area,” explains Roberto Solari, chief executive of MRC Technology, the technology transfer arm… CONTINUE READING